World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
162
Citations
148067
World Ranking
694
National Ranking
11

Lars Køber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lars Køber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,640 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lars Køber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lars Køber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 162 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lars Køber is affiliated with Copenhagen University Hospital in Denmark. Their primary area of research is within Medicine, encompassing 1,709 publications. The main subfields of their study include Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery, and Radiology, Nuclear Medicine and Imaging.

The scientist's research focuses on several key topics, including Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Diabetes Treatment and Management, Cardiac Imaging and Diagnostics, Cardiac Valve Diseases and Treatments, Acute Myocardial Infarction Research, and Infective Endocarditis Diagnosis and Management.

Lars Køber has contributed to research published in several prominent journals. The most frequent publication venues are:

  • European Heart Journal
  • European Journal of Heart Failure
  • Circulation
  • Journal of the American College of Cardiology
  • American Heart Journal

Their recent notable papers include:

  • 2023 ESC Guidelines for the management of acute coronary syndromes, 2023, European Heart Journal
  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2023, European Heart Journal
  • 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), 2024, European Heart Journal
  • 2024 ESC Guidelines for the management of chronic coronary syndromes, 2024, European Heart Journal
  • 2023 ESC Guidelines for the management of endocarditis, 2023, European Heart Journal

They have collaborated frequently with co-authors including Emil Loldrup Fosbøl, Christian Torp-Pedersen, Gunnar Gislason, John J.V. McMurray, and Scott D. Solomon.

Best Publications

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

    Stamatis Adamopoulos;Stefan D. Anker;Volkmar Falk;Lars Køber

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau

  • Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest

    Niklas Nielsen;Jørn Wetterslev;Tobias Cronberg;David Erlinge

  • Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

    Nagesh S Anavekar;John J V McMurray;Eric J Velazquez;Scott D Solomon

  • A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

    Køber L;Torp-Pedersen C;Carlsen Je;Bagger H

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

    Marcus D. Flather;Salim Yusuf;Lars Køber;Marc Pfeffer

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

    Lars Køber;Jens J. Thune;Jens J. Thune;Jens C. Nielsen;Jens C. Nielsen;Jens Haarbo;Jens Haarbo

  • Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

    Douglas L. Mann;John J.V. McMurray;Milton Packer;Karl Swedberg

  • Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

    C Torp-Pedersen;M Møller;P E Bloch-Thomsen;L Køber

  • Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

    Mads Wissenberg;Freddy K. Lippert;Fredrik Folke;Peter Weeke

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

    Søren L Kristensen;Søren L Kristensen;Rasmus Rørth;Rasmus Rørth;Pardeep S Jhund;Kieran F Docherty

  • Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.

    Stuart J. Pocock;Cono A. Ariti;John J. V. McMurray;Aldo Pietro Maggioni

  • Increased Mortality after Dronedarone Therapy for Severe Heart Failure

    Lars Køber;Christian Torp-Pedersen;John J.V. McMurray;Ole Gøtzsche

  • Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

    John J.V. McMurray;William T. Abraham;Kenneth Dickstein;Lars Køber

  • Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

    Jonas Bjerring Olesen;Gregory Y H Lip;Anne-Lise Kamper;Kristine Hommel

  • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

    Morten L. Hansen;Rikke Sørensen;Mette T. Clausen;Marie Louise Fog-Petersen

Frequent Co-Authors

Christian Torp-Pedersen
Christian Torp-Pedersen Aalborg University
Gunnar H. Gislason
Gunnar H. Gislason Copenhagen University Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Christian Hassager
Christian Hassager University of Copenhagen
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow
Jesper Hastrup Svendsen
Jesper Hastrup Svendsen Copenhagen University Hospital
Karl Swedberg
Karl Swedberg University of Gothenburg
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare programs can provide flexible and convenient pathways into the medical field, especially if you’re seeking alternatives to a traditional M.D. Online nursing degrees are a popular option. For those interested in advanced practice, a dnp program without clinical hours can help reduce in-person requirements, making it possible to balance work and study.

If you’re looking to enter the field quickly, accredited lpn programs can help you qualify as a Licensed Practical Nurse in a short period of time. For those passionate about mental health, the fastest pmhnp program can prepare you to become a Psychiatric Mental Health Nurse Practitioner, often in just two years.

Beyond clinical roles, management positions in healthcare are in high demand. Consider pursuing the cheapest online healthcare administration degree to develop leadership skills for hospital or clinic settings.

Each pathway offers unique benefits and entry requirements, and choosing the right option depends on your career goals, timeline, and interests.

Best Scientists Citing Lars Køber

Trending Scientists

Recently Published Articles